Fast track lung cancer service in a tertiary care centre

R. A. Mustafa, R. Mogal, P. K. Plant, M. E. J. Callister (Leeds, United Kingdom)

Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Session: Epidemiology and management of lung cancer
Session type: E-Communication Session
Number: 4683
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Abstract

Background: Leeds is the largest Lung Cancer centre in the UK1.
Aim: To audit our practice against the UK Department of Health (DoH) standards & Local guidelines.
Methods: Prospective audit of patients referred to the Fast track Lung cancer clinic from 03.09.08 to 29.10.08.
Results: 160 patients attended the clinic. 38% (n=60) were diagnosed with Lung cancer out of which 47% (n=28) received best supportive care (BSC), 13% (n=8) had radical surgery & 40% (n=24) had chemo &/radiotherapy. 6% (n=9) had cancers of other sites. 49% (n=78) had a benign diagnosis & 8% (n=12) were enrolled for radiological monitoring. 6.6 % (n=4) breached the 62-day referral to treatment cut off, 75% (n=3) of these required surgical staging.

Summary of Results
Median & Range (Days)DoH TargetUnit TargetTarget achieved (%)
Referral to first out-patient appointment (OPA)7 (1-15)14 days14 days98
CT prior to BronchoscopyNA100%100%100
Bronchoscopy to Histology6 (2-17)7 days7 days75
PET prior to referral for Radical TreatmentNA100%100%100
Referral to completion of diagnostics (Triage)15 (2-50)NA31 days96
Triage to OPAOncology OPA: 5 (1-22), Surgical OPA: 15.5 (2-22)NA7 daysOncology: 68, Surgery: 33
Thoracic Surgery or Oncology OPA to 1st definitive treatmentChemo &/Radiotherapy: 6 (1-19), Surgery: 16 (6-36)31 days31 days97
Initial referral to 1st definitive treatmentChemo &/Radiotherapy: 36 (16-70) ,Surgery: 53 (34-81), BSC: 18.5 (7-46)62 days62 days93


Conclusion: The audit confirms a fast & equitable diagnositic pathway for all high risk patients. Patients requiring surgical staging are more likely to breach the 62 day target.
Reference: 1) LUCADA 2008.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. A. Mustafa, R. Mogal, P. K. Plant, M. E. J. Callister (Leeds, United Kingdom). Fast track lung cancer service in a tertiary care centre. Eur Respir J 2009; 34: Suppl. 53, 4683

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

HOWES Timothy - 14.09.2009 12:41
Fast Track lung Cancer Service in a tertiary care centre
Very helpful audit. I notice that there were 60 (ish) cancers and 78 in the "benign" group. Do you feel that this ratio is about right" or that to pick up all cancers with a service like this one would expect a higher number in the "benign" category? Did any of the "benign" prove to be malignant at a later date? Thank you.
You must Login to comment this presentation.


Related content which might interest you:
Collateral impact of COVID19 pandemic on lung cancer services in a tertiary referral centre
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021


Determining the perception of lung cancer screening programme amongst medical patients in single tertiary centre.
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019


Improving the pleural procedures pathway in a tertiary cardiothoracic and cancer centre
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Rapid access lung cancer clinics
Source: Eur Respir J 2002; 20: Suppl. 38, 77s
Year: 2002

Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey
Source: Eur Respir J, 51 (5) 1702405; 10.1183/13993003.02405-2017
Year: 2018



Interstitial lung disease at a district general hospital: When are patients referred to tertiary care?
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019


Utility of a unique one stop rapid access service for the diagnosis of lung cancer from patients in primary care in Liverpool
Source: Eur Respir J 2001; 18: Suppl. 33, 63s
Year: 2001

An audit of lung cancer care highlighting the need for change in current practice in the district general hospital setting
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


Impact of a lung cancer screening programme on a London hospital service
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


Spectrum of diffuse parenchymal lung diseases at a tertiary care center in India
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Thoracic cancer patients and Covid-19: experience from a portuguese tertiary care unit
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021


Pulmonary rehabilitation in the tertiary care setting
Source: International Congress 2015 – PF ELF/ERS session:Improving adherence and outcomes in pulmonary rehabilitation
Year: 2015



Rapid access lung cancer clinics: do you have one?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Overcoming a stigma: the lung cancer patient in the intensive care unit
Source: Eur Respir J 2008; 31: 3-5
Year: 2008


Use of the European society objective score (ESOS.01) as an outcome evaluation tool for lung cancer surgery in a tertiary care hospital
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009


Reducing unscheduled attendances at hospital due to lung cancer via a rapid access flexible clinic
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011

Patient’s contacts with primary health care regarding specific lung cancer symptoms the year prior to diagnosis
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013

Palliative care throughout the lung cancer continuum
Source: International Congress 2017 – State of the art session: "Lung cancer"
Year: 2017


Benefits from a program for “early interstitial lung diseases” in primary care centers
Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Year: 2017